|
|
Ledoeje Bygade 23 B
Ledoeje, DK 2765 Denmark
phone:(45) 4450 1960
fax:(45) 4450 1962
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.rheoscience.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Services for biopharmaceutical companies developing drugs targeting diabetes and obesity. |
|
| Management |
| Philip Just Larsen, M.D., Ph.D., Chief Executive Officer; Niels Vrang, M.D, Ph.D., Manager |
| |
|
|
| |
|
| Keywords |
| diabete, obesity, pre-clinical research, metabolic syndrome |
|
|
|
| Description |
|
Rheoscience is an independent research company providing services to biopharmaceutical companies developing drugs targeting diabetes and obesity. |
|
| Technology / Differentiation |
| Using unique animal models closely mimicking the human metabolic syndrome Rheoscience ensures fast progression of lead candidates into clinical research programmes. In addition to its contract research programmes Rheoscience generates intellectual property rights via joint-venture projects and an internal target discovery program driven by a proprietary gene hunting methodology. |
|
|
| Funding |
| Rheoscience generates revenue by providing pre-clinical research services to pharmaceutical companies. |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members